The New Drug Application for grazoprevir/elbasvir (100mg/50mg) is based in part upon data from the pivotal C-EDGE clinical trials program, as well as the C-SURFER and C-SALVAGE trials.
Demande fir eng nei Drogenofhängeger "Grazoprevir / Ilbasvir" (100 mg / 50mg) baséiert zu engem Deel op Donnéeën aus dem Medeziner Prozess Programm C-EDGE ofgeleet, wéi och Séminairen Tester C-SURFER an C-SALVAGE.